Synaptic Mechanisms in Schizophrenia Treatment

Schizophrenia is increasingly viewed as a disorder of disturbed synaptic connectivity, where aberrant glutamatergic and dopaminergic signalling converge to produce the core symptoms of psychosis and cognitive dysfunction. At the heart of this disturbance lies the postsynaptic density (PSD), a protein‐rich scaffold that organises receptors, kinases and adaptor proteins to modulate synaptic plasticity. Hypofunction of N-methyl-D-aspartate receptors (NMDARs), altered dopamine D2 receptor (D2R) occupancy and dysregulation of intracellular cascades such as cAMP–protein kinase A and β-arrestin pathways impair long‐term potentiation and spine architecture. Conventional antipsychotics act principally through D2R antagonism, but their efficacy is limited by side effects and treatment resistance in a substantial minority of patients. Emerging strategies target synaptic homeostasis more broadly, aiming to restore glutamate receptor function, refine dopamine transporter (DAT) activity or modulate PSD composition. Insights into metabolic influences on synaptic proteins, and the discovery of non-canonical mechanisms such as receptor chaperoning or sodium channel modulation, hold promise for novel, synapse-based therapeutics that address both positive and cognitive symptoms.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Synaptic Mechanisms in Schizophrenia Treatment publication trend

The graph below shows the total number of articles in synaptic mechanisms in schizophrenia treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Synaptic plasticity: The capacity of synapses to strengthen or weaken over time, essential for learning and memory.

Postsynaptic density (PSD): A specialised protein matrix beneath the postsynaptic membrane that organises receptors and signalling molecules.

N-methyl-D-aspartate receptor (NMDAR): A subtype of glutamate receptor critical for calcium-mediated synaptic strengthening and neuroplasticity.

Dopamine D2 receptor (D2R) occupancy: The proportion of D2 receptors bound by an antagonist or agonist, directly correlating with antipsychotic efficacy.

References

1. Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment. Molecular Psychiatry (2023).
2. Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia. Cells (2023).
3. Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia. International Journal of Molecular Sciences (2023).